Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,078
Closed -$1.33M 119
2025
Q1
$1.33M Buy
8,078
+497
+7% +$82.6K 0.49% 80
2024
Q4
$1.24M Sell
7,581
-87
-1% -$15.6K 0.44% 81
2024
Q3
$1.5M Buy
7,668
+418
+6% +$77K 0.55% 75
2024
Q2
$1.26M Sell
7,250
-1,139
-14% -$190K 0.52% 74
2024
Q1
$1.42M Buy
8,389
+178
+2% +$33.3K 0.62% 66
2023
Q4
$1.62M Buy
8,211
+354
+5% +$62.7K 0.77% 47
2023
Q3
$1.37M Buy
7,857
+2,423
+45% +$440K 0.75% 52
2023
Q2
$936K Buy
+5,434
New +$939K 0.51% 81

Other funds holding ZTS

Alaethes Wealth's ZTS Position: Q2 2025 in Review

Alaethes Wealth sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 8,078 shares — an estimated $1.33M sold.

Alaethes Wealth first reported a position in ZTS in Q2 2023 and held it in 8 quarters. The position peaked at $1.62M in Q4 2023. 1,872 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Alaethes Wealth reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • Alaethes Wealth sold 8,078 Zoetis shares in Q2 2025, an estimated $1.33M.
  • Alaethes Wealth first reported a position in Zoetis in Q2 2023 and held it in 8 quarters.
  • Alaethes Wealth's Zoetis position peaked at $1.62M in Q4 2023.
  • 1,872 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Alaethes Wealth's 13F filing for Q2 2025, filed 15 Aug 2025.